Fiscal 2020 targets of ¥540 billion in revenue and ¥32.5 billion in operating profit
First written in FY2019. . Latest entry: FY2020.
The whole theme swung hardest in 2021: 17 of 77 companies on the "Worse" side.
- FY2020Revenue exceeded the target, while operating profit fell shortAnnual report
「During the current consolidated fiscal year, the Company worked to strengthen relationships with medical institutions and expand stores located alongside medical institutions to support further growth in the dispensing business, while also developing and introducing various systems and reviewing personnel programs to strengthen sales capabilities and improve productivity. As a result, revenue was ¥541.964 billion, up 11.0% year on year, operating profit was ¥29.762 billion, up 15.3%, and ROE was 11.9%.」
Compared with the existing fiscal 2020 targets of ¥540 billion in revenue and ¥32.5 billion in operating profit, revenue exceeded the target while operating profit fell short. - FY2019First statedAnnual report
「The Group set numerical targets for fiscal 2020 of ¥540 billion in revenue and ¥32.5 billion in operating profit. Having completed the phase of establishing its management platform through system upgrades and reviews of various programs, the Group aims to achieve its medium-term targets by shifting to a more proactive management approach from fiscal 2018, promoting its Total Healthcare Strategy centered on the dispensing business, shifting sales promotion methods to digital channels, and improving productivity through work-style reforms and other measures.」
New numerical targets for revenue and operating profit were explicitly set for fiscal 2020, with dispensing services, digital sales promotion, work-style reforms and productivity improvements identified as the means of achieving them.